Emmons Brendan R, Carreira Dominic S
Peachtree Orthopedics, Atlanta, GA, USA.
Foot Ankle Orthop. 2019 Apr 2;4(2):2473011418814427. doi: 10.1177/2473011418814427. eCollection 2019 Apr.
Interposition arthroplasty of the first MTP joint has recently experienced renewed interest as a treatment for hallux rigidus. The purpose of this study was to systematically review the rapidly expanding literature on PRO following interposition arthroplasty of the first MTP joint.
PubMed Central, Embase, and the Cochrane Central Register for Controlled Trials (CENTRAL) were searched. Inclusion criteria included length of time to follow-up, number of patients, outcome measure, and use of allogeneic or autogenous soft tissue or a synthetic matrix as interposition.
20 studies were included in the review, comprising 498 patients and 539 feet with mean time to follow-up of 4.5 years. The most common substance used for interposition in the included studies was autogenous first MTPJ capsular tissue, a technique reported on in 12 (60.0%) of the included articles. In studies reporting preoperative and postoperative outcomes by way of a standardized outcome scoring system, mean group improvements exceed minimal clinically important differences in the majority of studies. Eighty-five percent of the studies included in this review were of Level IV quality evidence, and of this subset of studies, 70.6% were of a retrospective nature. Progression to further surgery was observed in 3.8% of toes. The most common complication reported was transfer metatarsalgia of 1 or more lesser toes, observed in up to 57.9% of patients in one study.
Interposition arthroplasty appears to be a viable option for the treatment of moderate to severe hallux rigidus in patients looking to salvage motion through the first metatarsophalangeal joint. A wide array of autogenous, allogeneic, and synthetic implant materials have surfaced in recent years, but long-term follow-up and prospective, comparative study designs with low risk of bias are limited.
Level IV, systematic review of Level III-IV studies.
第一跖趾关节间置关节成形术作为治疗僵硬性拇趾的方法最近重新受到关注。本研究的目的是系统回顾第一跖趾关节间置关节成形术后关于患者报告结局(PRO)的迅速增长的文献。
检索了PubMed Central、Embase和Cochrane对照试验中央注册库(CENTRAL)。纳入标准包括随访时间长度、患者数量、结局指标以及使用同种异体或自体软组织或合成基质作为间置物。
本综述纳入了20项研究,共498例患者和539只足,平均随访时间为4.5年。纳入研究中最常用的间置物是自体第一跖趾关节囊组织,12篇(60.0%)纳入文章报道了该技术。在通过标准化结局评分系统报告术前和术后结局的研究中,大多数研究中平均组内改善超过最小临床重要差异。本综述纳入的研究中85%为IV级质量证据,在这一子集研究中,70.6%为回顾性研究。3.8%的趾出现了进一步手术的情况。报告的最常见并发症是1个或多个小趾的转移性跖骨痛,在一项研究中高达57.9%的患者中观察到。
对于希望通过第一跖趾关节挽救活动度的中重度僵硬性拇趾患者,间置关节成形术似乎是一种可行的选择。近年来出现了各种各样的自体、异体和合成植入材料,但长期随访以及低偏倚风险的前瞻性、比较性研究设计有限。
IV级,III-IV级研究的系统综述。